Cytokine treatment optimises the immunotherapeutic effects of umbilical cord-derived MSC for treatment of inflammatory liver disease
Authors:
- Samantha F. H. de WitteSWSamantha F. H. de Witte
- Ana M. MerinoAMAna M. Merino
- Marcella FranquesaMarcella Franquesa
- Tanja StriniTSTanja Strini
- Johanna A. A. van ZoggelJZJohanna A. A. van Zoggel
- Sander S. KorevaarSKSander S. Korevaar
- Franka LukFLFranka Luk
- Madhu GargeshaMGMadhu Gargesha
- Lisa O’flynnLOLisa O’flynn
- Debashish RoyDRDebashish Roy
- Steve J. EllimanSESteve J. Elliman
- Philip N. NewsomePNPhilip N. Newsome
Open Access
- 8 June 2017
- journal article
- research article
- Published by Springer Nature in Stem Cell Research & Therapy
- Vol. 8 (1) , 1-12
Abstract
Mesenchymal stromal cells (MSC) possess immunomodulatory properties and low immunogenicity, both crucial properties for their development into an effective cellular immunotherapy. They have shown benefit in clinical trials targeting liver diseases; however the efficacy of MSC therapy will benefit from improvement of the immunomodulatory and immunogenic properties of MSC. MSC derived from human umbilical cords (ucMSC) were treated for 3 days in vitro with various inflammatory factors, interleukins, vitamins and serum deprivation. Their immunogenicity and immunomodulatory capacity were examined by gene-expression analysis, surface-marker expressions, IDO activity, PGE2 secretion and inhibition of T cell proliferation and IFNγ production. Furthermore, their activation of NK cell cytotoxicity was investigated via CD107a expression on NK cells. The immunomodulatory capacity, biodistribution and survival of pre-treated ucMSC were investigated in a CCl4-induced liver disease mouse model. In addition, capacity of pre-treated MSC to ameliorate liver inflammation was examined in an ex vivo liver inflammation co-culture model. IFN-γ and a multiple cytokine cocktail (MC) consisting of IFN-γ, TGFβ and retinoic acid upregulated the expression of immunomodulatory factor PD-L1 and IDO activity. Subsequently, both treatments enhanced the capacity of ucMSC to inhibit CD4 and CD8 T cell proliferation and IFN-γ production. The susceptibility of ucMSC for NK cell lysis was decreased by IFN-β, TGFβ and MC treatment. In vivo, no immunomodulation was observed by the ucMSC. Four hours after intravenous infusion in mice with CCl4-induced inflammatory liver injury, the majority of ucMSC were trapped in the lungs. Rapid clearance of ucMSC(VitB6), ucMSC(Starv + VitB6) and ucMSC(MC) and altered bio-distribution of ucMSC(TGFβ) compared to untreated ucMSC was observed. In the ex vivo co-culture system with inflammatory liver slices ucMSC(MC) showed significantly enhanced modulatory capacity compared to untreated ucMSC. The present study demonstrates the responsiveness of ucMSC to in vitro optimisation treatment. The observed improvements in immunomodulatory capacity as well as immunogenicity after MC treatment may improve the efficacy of ucMSC as immunotherapy targeted towards liver inflammation.Keywords
Funding Information
- Seventh Framework Programme (602363, 602363)
- Innovative Medicines Initiative Joint Undertaking (115188)
This publication has 45 references indexed in Scilit:
- Interleukin-17A-Induced Human Mesenchymal Stem Cells Are Superior Modulators of Immunological FunctionStem Cells, 2015
- Effects of Hypoxia on the Immunomodulatory Properties of Adipose Tissue-Derived Mesenchymal Stem cellsFrontiers in Immunology, 2013
- Human umbilical cord mesenchymal stem cells improve liver function and ascites in decompensated liver cirrhosis patientsJournal of Gastroenterology and Hepatology, 2012
- Human mesenchymal stem cells derived from induced pluripotent stem cells down-regulate NK-cell cytolytic machineryBlood, 2011
- CD271 antigen defines a subset of multipotent stromal cells with immunosuppressive and lymphohematopoietic engraftment-promoting propertiesHaematologica, 2010
- Pulmonary Passage is a Major Obstacle for Intravenous Stem Cell Delivery: The Pulmonary First-Pass EffectStem Cells and Development, 2009
- Interactions Between Human Mesenchymal Stem Cells and Natural Killer CellsStem Cells, 2005
- Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase–mediated tryptophan degradationBlood, 2004
- Homing of in vitro expanded Stro-1- or Stro-1+ human mesenchymal stem cells into the NOD/SCID mouse and their role in supporting human CD34 cell engraftmentBlood, 2004
- HLA expression and immunologic propertiesof differentiated and undifferentiated mesenchymal stem cellsExperimental Hematology, 2003